The analysis of breakthrough research on Primary Biliary Cholangitis (PBC) with Kris Kowdley

Dr Kris Kowdley comments on some of the key data in primary biliary cholangitis, presented at The Liver Meeting 2023, including the ELATIVE trial involving elafibranor.
This video is part of the Independent Medical Education program entitled, 'Improving PBC outcomes by prioritising patients' needs'. This expert-led program will allow you to effectively evaluate treatment response in your patients, and make informed decisions on individualized patient management strategies, regarding therapy response, symptom management, clinical guidelines, and new advances in the PBC treatment landscape.
To learn more about the full program, visit pbc.ime.springerhealthcare.com
---
This program is made possible thanks to an independent educational grant from Ipsen.